BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 11232202)

  • 21. Advances in the pathogenesis and treatment of type-1 and type-2 hepatorenal syndrome.
    Arroyo V; Terra C; Ginès P
    J Hepatol; 2007 May; 46(5):935-46. PubMed ID: 17391801
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hepatorenal syndrome].
    Saner F; Hertl M; Broelsch CE
    Internist (Berl); 2001 Dec; 42(12):1666-71; quiz 1672-3. PubMed ID: 11793605
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hepatorenal syndrome].
    Lautrette A; Liotier J; Deteix P; Souweine B
    Nephrol Ther; 2009 Apr; 5(2):150-6. PubMed ID: 18514053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of ascites and hepatorenal syndrome.
    Piano S; Tonon M; Angeli P
    Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapy insight: Management of hepatorenal syndrome.
    Cárdenas A; Ginès P
    Nat Clin Pract Gastroenterol Hepatol; 2006 Jun; 3(6):338-48. PubMed ID: 16741553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Update on hepatorenal syndrome].
    Blaise P; Moonen M; Rorive G
    Nephrologie; 2002; 23(1):11-7. PubMed ID: 11887572
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hepatorenal syndrome: diagnosis, treatment and prevention].
    Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
    Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiology, diagnosis and clinical management of hepatorenal syndrome: from classic to new drugs.
    Barbano B; Sardo L; Gigante A; Gasperini ML; Liberatori M; Giraldi GD; Lacanna A; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 Jan; 12(1):125-35. PubMed ID: 24678726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatorenal syndrome: a review.
    Testino G; Ferro C
    Hepatogastroenterology; 2010; 57(102-103):1279-84. PubMed ID: 21410072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recent advances in hepatorenal syndrome.
    Arroyo V; Torre A; Guevara M
    Trop Gastroenterol; 2005; 26(1):13-20. PubMed ID: 15974232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathophysiology and treatment of hepatorenal syndrome.
    Wong F; Blendis L
    Gastroenterologist; 1998 Jun; 6(2):122-35. PubMed ID: 9660529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Current management and novel therapeutic strategies for refractory ascites and hepatorenal syndrome.
    Suzuki H; Stanley AJ
    QJM; 2001 Jun; 94(6):293-300. PubMed ID: 11391027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degree of hepatic dysfunction and improvement of renal function predict survival in patients with HRS type I: a retrospective analysis.
    Appenrodt B; Zielinski J; Brensing KA; Heller J; Sauerbruch T; Schepke M
    Eur J Gastroenterol Hepatol; 2009 Dec; 21(12):1428-32. PubMed ID: 19794309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of hepatorenal syndrome].
    Walter E
    Praxis (Bern 1994); 1997 Jan; 86(4):102-3. PubMed ID: 9064719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathogenesis and management of the hepatorenal syndrome.
    Laffi G; La Villa G; Gentilini P
    Semin Liver Dis; 1994 Feb; 14(1):71-81. PubMed ID: 8016664
    [No Abstract]   [Full Text] [Related]  

  • 37. [The therapy of the hepatorenal syndrome in liver cirrhosis].
    Biecker E; Brensing KA; Perz J; Woitas R; Sauerbruch T
    Dtsch Med Wochenschr; 1999 Sep; 124(36):1039-42. PubMed ID: 10506842
    [No Abstract]   [Full Text] [Related]  

  • 38. Diagnosis and treatment of hepatorenal syndrome.
    Ginès P
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):945-57. PubMed ID: 11139348
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis.
    Busk TM; Bendtsen F; Møller S
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):523-30. PubMed ID: 23325273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.